NICE to support new valuation study for England for EQ-5D-5L questionnaire

24 October 2019 - Study will measure public’s preference for different health states. ...

Read more →

The impact of moving from the EQ-5D-3L to the -5L in NICE technology appraisals

11 January 2019 - The EQ-5D instrument is NICE’s preferred measure of health-related quality of life in adults.  ...

Read more →

Evaluating progression-free survival as a surrogate outcome for health-related quality of life in oncology

1 October 2018 - Progression-free survival has become a commonly used outcome to assess the efficacy of new cancer drugs. However, ...

Read more →

Differentiation of health-related quality of life outcomes between five disease areas: results from an international survey of patients

25 September 2018 - Health-related quality of life data generated by generic, preference-based instruments are highly demanded in health policy decision ...

Read more →

Metastatic breast cancer: highly selective post-hoc analysis rather than complete publication of quality of life data

13 June 2018 - IQWiG employees criticise the publication practice of PALOMA-2 study authors. ...

Read more →

3L, 5L, What the L? A NICE conundrum

20 May 2018 - For many years, NICE has recommended use of the EQ-5D-3L and its value set for the UK.  ...

Read more →

What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews

27 April 2018 - Finch assessed the evidence on the validity and responsiveness of five commonly used preference-based instruments, the ...

Read more →

The “utility” in composite outcome measures

14 November 2017 - Measuring what is important to patients. ...

Read more →

Quality of life: an important element of treatment value

9 November 2017 - In the era of platinum-based chemotherapy, attempts to improve the quality of life of patients with advanced ...

Read more →

In search of a common currency: a comparison of seven EQ-5D-5L value sets

24 October 2017 - The recently published EQ-5D-5L value sets from Canada, England, Japan, Korea, the Netherlands, Spain, and Uruguay are ...

Read more →

NICE to work with partners on developing new ways to measure quality of life across health and social care

13 June 2017 - NICE is taking part in a project that will examine how quality of life measures used to ...

Read more →

EQ-5D and the EuroQol Group: past, present and future

17 March 2017 - The Office of Health Economics has posted a new item entitled 'EQ-5D and the EuroQol Group: Past, ...

Read more →

Four years of early benefit assessment of new drugs in Germany: a qualitative study on methodological requirements for quality of life data

12 March 2017 - This study determined methodological requirements for health-related quality of life measurement and data presentation in the early ...

Read more →

Quality of life, overall survival and costs of cancer drugs approved based on surrogate outcomes

14 February 2017 - The lack of evidence of a clinically meaningful benefit for many cancer drugs approved by the US ...

Read more →

Quality of life, overall survival, and costs of cancer drugs approved based on surrogate endpoints

29 November 2016 - The lack of evidence of a clinically meaningful benefit for many cancer drugs approved by the US ...

Read more →